Shortcodes

ABCURO ANNOUNCES $8M SERIES A FINANCING

This financing will advance the preclinical development of their programs in autoimmunity and immuno-oncology. Cambridge, MA – Abcuro, a leading biotechnology company focused on immunology therapeutics, announced the completion of a $8M Series A financing round.  Partners Innovation Fund, Kaitai … Read More